Ani Pharmaceuticals (ANIP) Interest & Investment Income (2010 - 2026)
Ani Pharmaceuticals' (ANIP) quarterly Interest & Investment Income came in at -$3.6 million in Q2 2026, up 33.14% year-over-year from -$2.7 million in Q2 2025, and up 3.53% quarter-over-quarter from -$3.8 million in Q1 2026.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Interest & Investment Income (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has disclosed Interest & Investment Income across 17 years of filings, most recently posting -$3.6 million for Q2 2026.
- In Q2 2026, Interest & Investment Income rose 33.14% year-over-year to -$3.6 million; the TTM figure through Jun 2026 stood at -$16.5 million (up 14.14% YoY), while the FY2025 annual figure was -$20.1 million, down 13.96% from the prior year.
- Interest & Investment Income came in at -$3.6 million for Q2 2026 at Ani Pharmaceuticals, up from -$3.8 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of -$2.3 million in Q3 2024 to a low of -$7.7 million in Q1 2023.
- Average Interest & Investment Income over 5 years is -$5.6 million, with a median of -$5.6 million recorded in 2023.
- Year-over-year, Interest & Investment Income tumbled 190.91% in 2022 and jumped 63.57% in 2024.
- Over 5 years, Interest & Investment Income stood at -$7.5 million in 2022, then advanced by 23.45% to -$5.7 million in 2023, then retreated by 4.68% to -$6.0 million in 2024, then climbed by 26.67% to -$4.4 million in 2025, then rose by 17.57% to -$3.6 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were -$3.6 million in Q2 2026, -$3.8 million in Q1 2026, and -$4.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 31.57 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | -55.04 Mn |
| 5 | Bausch Health Companies | 2.38 Bn | 541.37 Mn | 2.10 Bn | 11.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -16.41 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -3.64 Mn |
| 8 | Amphastar Pharmaceuticals | 992.25 Mn | 702.12 Mn | 93.47 Mn | 2.29 Mn |
| 9 | Fennec Pharmaceuticals | 410.57 Mn | 369.32 Mn | 17.15 Mn | 287,000.00 |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.64 Mn |
| Mar 31, 2026 | -3.77 Mn |
| Dec 31, 2025 | -4.41 Mn |
| Sep 30, 2025 | -4.73 Mn |
| Jun 30, 2025 | -5.44 Mn |
| Mar 31, 2025 | -5.48 Mn |
| Dec 31, 2024 | -6.02 Mn |
| Sep 30, 2024 | -2.33 Mn |
| Jun 30, 2024 | -4.66 Mn |
| Mar 31, 2024 | -4.60 Mn |
| Dec 31, 2023 | -5.75 Mn |
| Sep 30, 2023 | -6.40 Mn |
| Jun 30, 2023 | -7.10 Mn |
| Mar 31, 2023 | -7.70 Mn |
| Dec 31, 2022 | -7.51 Mn |
| Sep 30, 2022 | -7.26 Mn |
| Jun 30, 2022 | -6.67 Mn |
| Mar 31, 2022 | -6.61 Mn |
| Dec 31, 2021 | -4.44 Mn |
| Sep 30, 2021 | -2.50 Mn |